상황
A pharmaceutical company faces repeated delays in filing new drug applications, risking market access and compliance. This analysis maps out potential root causes across multiple domains.
이 도면에 담긴 내용
그 이면의 의사결정을 읽어 보세요.
01
Prioritize process and system improvements
02
Enhance training programs
03
Implement real-time tracking dashboards
When diagnosing delays in regulatory submissions, especially for eCTD-based filings, and aiming to identify systemic issues.